Due to its genetic amenability coupled with recent advances in genome editing, the zebrafish 20 serves as an excellent model to examine the function of both coding and non-coding elements. 21 Recently, the non-coding genome has gained prominence due to its critical role in development 22 and disease. Here, we have re-purposed the Ac/Ds maize transposition system to reliably screen 23 and efficiently characterise zebrafish enhancers, with or without germline propagation. We 24 further utilised the system to stably express guide RNAs in microinjected embryos enabling 25 tissue-specific CRISPR/dCas9-interference (CRISPRi ) knockdown of lncRNA and enhancer 26 activity without disrupting the underlying genetic sequence. Our study highlights the utility of 27 Ac/Ds transposition for transient epigenome modulation of non-coding elements in zebrafish. 28 102 non-coding genomic elements. By harnessing its reliability and efficiency for somatic 103 integration, the toolkit can be robustly used either in transient and/or to complement 104 transgenic-based methods. 105 Results and Discussion 106 Ac/Ds transposition is more effective than Tol2 for transient integration of 107 transgenes in F 0 zebrafish embryos. 108 As a first step in re-purposing the maize Ac/Ds transposition system for zebrafish, we generated 109 a new enhancer/reporter construct (pVC-Ds-E1b:eGFP-Ds) for efficient and reproducible in 110 vivo testing of enhancer activity. The construct consists of the eGFP expression cassette under 111 the control of the zebrafish E1b minimal promoter (Becker et al., 2016) flanked by Ds elements 112 6
Introduction 29
The non-coding genome has risen to prominence in recent years following successive studies 30 highlighting its numerous roles in development and disease (Krijger and de Laat, 2016, Engreitz 31 et al., 2016) . The genome is populated by cis-regulatory elements called enhancers, which are 32 active in a tissue-specific fashion (Rickels and Shilatifard, 2018) and probing their functional et al., 2013) or four concatenated mSin3 repressive domains (SID4x) (Konermann et al., 2013) 86 to induce chromatin changes inhibitive of transcription. Crucially, as CRISPRi complexes are 87 directed to the TSS of target genes, this allows the perturbation of gene expression without 88 modifying the endogenous locus sequence, making it a well-suited tool to study the function of 89 non-coding genes (Thakore et al., 2015 , Konermann et al., 2015 , Liu et al., 2016 , Williams et al., 90 2018 . Similarly, ectopic activation of genes can be achieved by CRISPRa in specific cell types 91 using the VP64 activator domain (Mali et al., 2013) . The caveat to using these approaches in 92 the zebrafish embryo is the need for extended expression of sgRNAs, which is limited by the 93 current gold-standard of injecting in vitro-transcribed sgRNAs. In the absence of Cas9 protein, 94 uncapped and non-polyadenylated sgRNAs degrade quickly (Mir et al., 2018) . Therefore such 95 experiments can only be performed at the 1-cell stage and either have to be analysed during the 96 first 24-48 hours of development or sgRNA expression needs to be propagated to the germline. 97 Here, in addition to building zebrafish BAC transgenic lines expressing CRISPRi /a effectors 98 dCas9-SID4x and dCas9-VP64 in a tissue-specific fashion, we also generated and employed 99 Ac/Ds-integrated DNA constructs to deliver small guide RNAs constitutively in order to 100 transiently modulate the activity of non-coding elements in transgenic F 0 embryos in vivo. 101 Our Ac/Ds toolkit broadens the potential of the zebrafish embryo for rapid studies of the 'weak' enhancer resulted in comparable GFP + /Hoechst + signal, a much higher variability 142 between embryos was observed by the Tol2-mediated approach (Fig.1C) . 143 These results demonstrated a clear advantage of Ac/Ds-over 144 and in general transient expression systems using DNA constructs in zebrafish, as Ac/Ds 145 transposition yielded a higher number of construct integrations resulting in lower cell mosaicity 146 rate. This was particularly notable with a strong element such as the pax3a enhancer, where a 147 high number of cells showing consistent enhancer activity pattern were successfully labelled. 148 Furthermore, the utility of Ac/Ds in being able to inject both DNA and mRNA at lower 149 amounts is significant. Toxicity issues associated with the higher levels required for Tol2-based 150 somatic integration could be avoided, and lower amounts of DNA required for high integration 151 efficiency minimises ectopic activity from episomal expression of non-integrated plasmid. This 152 places the zebrafish embryo on par with the chick embryo as an excellent model for testing 153 enhancer activity transiently in injected F 0 embryos (Streit et al., 2013) . Taken together, we 154 demonstrated that Ac/Ds-mediated integration is not only more efficient for transgenes with 155 strong activity but at the same time more efficacious for transgenes with weaker activity. Figure 1 . Ac/Ds integration is more effective than Tol2 in F 0 embryos.
A Schematic of constructs containing a neural crest pax3a enhancer (cyan) positioned upstream of the zebrafish E1b minimal promoter (grey) and driving eGFP (green) expression harbouring either Ds-or Tol2-integration arms (black). 30 pg of either construct ("Ac/Ds" and "Tol2") was microinjected into Gt(FoxD3:mCherry) ct110aR embryos (to visualise neural tube) together with Ac or Tol2 mRNA, respectively. Live confocal imaging highlighted similar levels of neural crest cell labelling between 30 pg Ac/Ds and 150 pg Tol2, but 30 pg Tol2 injections yielded much weaker signal in comparison. B Labelling efficiencies of the Ac/Ds and Tol2 pax3a enhancer were quantified using immunohistochemistry and Imaris. Ac/Ds resulted in up to 9-fold increase (Student t-test; p=0.001) of GFP + /Hoechst + signal compared to Tol2. C The same approach in (B) was used to compare labelling efficiency of a sox10 enhancer with weak activity. Although both versions resulted in comparable GFP + /Hoechst + signal, Ac/Ds demonstrated less variability compared to Tol2. Scale bar: 40 µm.
In vivo characterisation of novel neural crest enhancers using Ac/Ds.
158
Having established the utility of Ac/Ds for testing enhancers in F 0 embryos, we further 159 characterised the pax3a and sox10 enhancers described earlier following germline transmission 160 ( Fig.2 , pax3a E5 and sox10 E2). We found that germline transmission rates for Ac/Ds-injected 161 embryos were comparable to Tol2, consistent with previous reports (Emelyanov et al., 2006, 162 Emelyanov and Parinov, 2008) . We also characterised three additional enhancers -one 163 predicted for pax3a and two for sox10 ( Fig.2 ; pax3a E4, sox10 E5 and E7) in both F 0 and 164 following germline transmission (pax3a E4), or in F 0 only (sox10 E5 and E7) (Supp. Fig.3 ). Zfin in situ data). Co-localisation of eGFP and pax3a mRNA transcripts in this region were 177 detected in F 0 -injected embryos, and this result was recapitulated in F 2 embryos,
178
Tg(pax3a enh5-E1b:eGFP) ox163 ( Fig.2A ). Pax3a E4 gave a similar result but with overall 179 weaker eGFP expression in both F 0 and F 2 , Tg(pax3a enh4-E1b:eGFP) ox162 (Supp. Fig.3) .
180
Next, we tested the co-localisation of Sox10 expression with sox10 E2, E5 and E7 activity 181 using immunohistochemistry to detect eGFP and endogenous Sox10 proteins. At 18 ss, sox10 is 182 strongly expressed in migratory neural crest within the cranial region ( Fig.2B , cartoon 183 reproduced from (Gavriouchkina et al., 2017) ). All sox10 enhancers demonstrated weak but 184 Sox10-specific activity in F 0 -injected embryos (Fig.2B , Supp. Fig.3 ). Remarkably, 185 sox10 E2-driven eGFP expression dramatically improved following germline transmission with a 186 much higher number of GFP + /Sox10 + cells being detected in Tg(sox10 enh2-E1b:eGFP) ox120 187 F 2 embryos ( Fig.2B ). Interestingly, this "germline-boosting" effect was not observed in five 188 other enhancer lines that we have propagated to the germline.
189
To recover integration sites of the transgene in a genome-wide fashion, we performed 190 splinkerette-PCR-NGS on a pool of GFP + F 2 embryos (Supp. Fig.4 result may represent most of the initial integration events still present in the F 1 germline, as 197 indicated by the 5,473 putative inserts identified in F 0 -injected embryos by Vrljicak et al..
198
Echoing the previous study, we also found a large proportion of integration sites (88.2%) to The results demonstrated by the weak sox10 E2 enhancer fortuitously highlighted the 203 potential for our approach to uncover candidates that would otherwise have been overlooked at 204 the F 0 screening stage if Tol2-integration was used. The higher likelihood of a false positive 205 result with Tol2 could influence a negative decision for the propagation of the transgene as a 206 reporter line, thus eliminating potential lines that could be biologically relevant. In short, we 207 showed that the Ac/Ds enhancer construct is a robust and useful tool to characterise putative 208 enhancers with both strong and weak activity. corresponding to flanking genomic regions on Ds-3' end (navy blue; splink Fwd) and Ds-5' end 221 (navy blue; splink Rv) were mapped to the zebrafish genome (GRCz10) and peaks corresponding 222 to integration sites were bioinformatically called (navy blue boxes). The sox10 locus is shown 223 as an example, with the position of sox10 E2 highlighted in orange. 88.2% of integration sites 224 partially/fully overlapped annotated repeat elements (blue; highlighted with dotted box), while 225 the remaining 11.8% (red; highlighted with dotted box) did not. Annotated introns, promoters 226 and exons were enriched (p<0.04) within all integration sites (purple bar chart). Transcription 227 termination sites (TTS) were also enriched (p<0.01) within integration sites that did not 228 overlap annotated repeat elements (red bar chart). Scale bar: 20 µm; 40 µm (B-stable (F2)).
229
Ac/Ds successfully expresses sgRNAs for transient tissue-specific CRISPRi.
230
The ability to knockdown non-coding elements in vivo is essential for the dissection of their 231 function. Currently, the most commonly used method to deliver sgRNAs for CRISPR/Cas9 in 232 zebrafish is via microinjection of in vitro-transcribed sgRNAs into single cell embryos. While 233 cost-effective and straightforward, this approach risks decreasing the efficiency for 234 CRISPR-mediated events in the embryo, as the uncapped and non-polyadenylated nature of 235 sgRNAs renders them sensitive to degradation in vivo (Mir et al., 2018) . This is particularly 236 pertinent if the desired goal is to perform CRISPR experiments in a tissue-specific fashion, as 237 unprotected sgRNAs injected in the absence of Cas9 protein or Cas9 mRNA are likely to be 238 diminished by the time a tissue-specific Cas9 protein is expressed many hours later in 239 development.
240
We took advantage of Ac/Ds to generate a constitutive sgRNA expression system that 241 employs a "transient transgenesis" approach for use in tissue-specific CRISPR/dCas9 242 (nuclease-deficient Cas9) modulation of targeted non-coding loci and enhancers in F 0 embryos. 243
To express sgRNAs, we cloned a cassette containing a zebrafish-specific U6a promoter driving 244 expression of sgRNAs (Yin et al., 2015) into a custom-made Ac/Ds mini-vector ( Fig.3A ,
245
Materials & Methods). The 20bp spacer region within the cassette was flanked by BsmBI 246 restriction sites to facilitate GoldenGate (Clarke et al., 2012) -like cloning of different sgRNAs 247 (Supp. Fig.5A ). We compared continuous expression of a scrambled sgRNA sequence from the 248 integrated Ac/Ds-U6a:sgRNA vector (pVC-Ds-DrU6a:sgRNA-Ds) and an in vitro-transcribed 249 sgRNA transcript by injecting 50 pg of vector (with 24 pg Ac mRNA) or 80 pg of transcript into 250 wild type embryos, followed by RT-PCR at 5 hours post injection (hpi), 24 hpi and 5 days post 251 injection (dpi). We found that sgRNA expression up to 5 dpi could only be detected using 252 Ac/Ds (Fig.3A) . To achieve tissue-specific (neural crest) expression of dCas9 fused to repressive 253 effector protein (SID4x) for CRISPR/dCas9-interference (CRISPRi ) at target regions ( Fig.3B ), 254
we generated BAC transgenic line TgBAC(sox10:dCas9-SID4x-2a-Citrine) ox117 ("ox117") by 255 taking advantage of the previously validated sox10 BAC clone (Trinh et al., 2017) . This 256 approach enabled neural crest-specific expression of dCas9-SID4x in an endogenous sox10 -like 257 fashion, under the control of regulatory elements embedded within the sox10 regulatory locus 258 contained in the BAC clone ( Fig.3C ).
259
We reasoned that the small size of the Ac/Ds-U6a:sgRNA mini-vector (<4.5kb), coupled 260 with the small load required for activity, would permit pooling of multiple sgRNAs. We tested a 261 load of up to 160 pg DNA per embryo, where the survival rate was ∼50% in our hands.
262
Multiplexing sgRNAs is crucial for CRISPRi, given previous studies demonstrating the 263 requirement for multiple sgRNAs to illicit successful knockdown (Qi et al., 2013 , Williams et al., 264 2018 . Previous evidence has also highlighted CRISPRi 's potential for strand-specific 265 mode-of-action when dCas9 is used to target transcription elongation, but not initiation, using 266 sgRNAs that bind the non-template strand (Qi et al., 2013) . To explore this possibility in the 267 zebrafish, we microinjected incrossed ox117 embryos with an Ac/Ds-sgRNA pool containing five 268 sgRNAs that target the TSS of STRG.15268.1, an antisense transcript overlapping sox9a 269 ("sox9a lncRNA"), while avoiding targeting of sox9a elongation (Supp. Fig.5B ). The sox9a 270 lncRNA was identified by de novo assembly (Pertea et al., 2015) of previously published neural 271 crest RNA-seq datasets (Trinh et al., 2017) and is preceded by a strong ATAC-seq peak at its 5' 272 terminus, indicative of promoter activity (Buenrostro et al., 2013) (Fig.3D , maroon track).
273
A major obstacle to the study of lncRNAs is their significantly lower levels of expression 274 compared to their protein-coding counterparts (Derrien et al., 2012) . To circumvent this issue 275 and quantify sox9a lncRNA levels following CRISPRi, we performed semi-quantitative 276 transcript-specific RT-PCR with βactin as endogenous control (Fig.3D ). To quantify sox9a 277 while taking into account potential strand-unspecific effects, sox9a was reverse-transcribed 278 using a gene-specific primer targeted at its 3'UTR and localised upstream of the five sgRNAs 279 targeting the TSS of sox9a lncRNA. Transcript levels were measured using qPCR as per 280 standard practice (Fig.3D ). We found modest knockdown (p=0.03) of sox9a lncRNA in the 281 presence of sgRNAs compared to scrambled sgRNAs or uninjected controls ( Fig.3D') , while 282 sox9a transcript levels were unaffected in the same samples ( Fig.3D") . These findings were 283 consistent with our observation that injected embryos were morphologically normal and support 284 recent evidence that lncRNAs were largely dispensable for development (Goudarzi et al., 2018) . 285
In short, we demonstrated that re-purposing of the Ac/Ds approach enabled constitutive 286 expression of sgRNAs in embryos in vivo following genomic integration of the construct into 287 somatic cells. By pooling multiple sgRNAs, we also provided proof-of-principle evidence that 288
CRISPRi could be achieved in a strand-specific fashion on a locus with overlapping antisense 289 transcription. As an aside, we have also generated modified versions of the Ac/Ds-sgRNA 290 vector containing RNA scaffolds for KRAB transcriptional repression (Zalatan et al., 2015) and 291 for the synergistic transcription activation mediator (SAM) system (Konermann et al., 2015) . 292
The latter can be coupled with the TgBAC(sox10:Cas9m4-VP64-2a-Citrine) ox118 line we have 293 also generated, to enable for CRISPR/dCas9-activation ( S1 S2 S3 S1 S2 S1 S2 S3 sox9a lncRNA (~200bp) * +sgRNAs scr.
-ve S1 S2 S3 S1 S2 S1 S2 S3 A A zebrafish U6a promoter is used to drive expression of an sgRNA cassette consisting of 297 spacer region (20bp target sequence), tracrRNA and a U6 termination sequence (U6stop). The 298 entire transgene is flanked by Ds integration arms (black). AcDs-U6a:sgRNA was microinjected 299 into incrossed ox117 embryos and its sgRNA transcript detected by RT-PCR (red arrows 300 indicate primers; product size 86bp) at 5 hours post-injection (hpi), 24 hpi and 5 days 301 post-injection (5 dpi). In parallel, embryos microinjected with in vitro-transcribed sgRNA (with 302 same sequence as AcDs version) were also accessed. At 5 dpi, sgRNA expression was only 303 detected in embryos microinjected with AcDs-U6a:sgRNA. B Nuclease-deficient Cas9 (green; 304 dCas9) fused to the SID4x repressor domain (violet) is targeted to a region-of-interest using 305 sgRNAs (red). The SID4x domain enables transcriptional repression via chromatin compaction, 306 possibly by recruiting histone deacetylases (HDACs). C A Sox10-specific CRISPRi transgenic 307 line, TgBAC(sox10:dCas9-SID4x-2a-Citrine) ox117 , was generated using BAC recombination and 308 Tol2-mediated transgenesis. A ribosome-skipping TaV-2a peptide (2a) mediates separation of 309 dCas9-SID4x from its Citrine reporter protein. The transgene successfully labels neural crest 310 (white arrows) and the otic vesicle (ov) in vivo. D Five AcDs-U6a:sgRNAs targeting the TSS of 311 STRG.15268.1, a transcript overlapping sox9a in the opposing strand ("sox9a lncRNA"), were 312 microinjected into ox117 incrossed embryos. Strand-specific reverse transcription (RT) was 313 performed using primers that bind specifically to the predicted 3' end of sox9a lncRNA (orange) 314 or the 3'UTR of sox9a mRNA (indigo). The sox9a mRNA RT primer is positioned upstream of 315 sox9a lncRNA's TSS target region. In both cases, βactin was also primed as an endogenous 316 control. Sox9a lncRNA and sox9a mRNA were measured using semi-quantitative PCR and 317 qPCR, respectively. D' Semi-quantitative PCR revealed a modest knockdown (Student t-test; 318 p=0.03) of sox9a lncRNA in the presence of sgRNAs compared to controls. D" Sox9a mRNA 319 transcript levels were unaffected by sox9a lncRNA CRISPRi, indicating a strand-specific 320 mode-of-action. Scale bar: 40 µm.
321
CRISPRi of sox10 enhancers affects Sox10 expression.
322
Finally, we investigated the functional relationship between sox10 E2, E5 and E7 enhancers, 323 characterised by our Ac/Ds enhancer assay, and endogenous sox10 expression using our 324 optimised CRISPRi approach (Fig.4A) , as enhancer effect on gene expression is thought to be 325 additive (Hay et al., 2016 , Will et al., 2017 . To test the contributions of multiple enhancers to 326 sox10 gene activity, TgBAC(sox10:dCas9-SID4x-2a-Citrine) ox117 incrossed embryos were 327 injected with a pool of 15 Ac/Ds sgRNAs targeting all three sox10 enhancers. Embryos were 328 fixed and immunohistochemistry performed to detect Citrine (cells expressing dCas9-SID4x) 329 and nuclei containing endogenous Sox10 protein (Materials & Methods). We identified three 330 different scenarios in terms of co-expression -(1) dCas9-SID4x + only* cells, (2) 331 sox10 + /dCas-SID4x + ** double-positive cells and (3) Sox10 + only cells (this scenario was 332 observed due to faint levels of Citrine at the stage of analysis) (Fig.4B ). We reasoned that such 333 a combined outcome and scenario (3) with a decrease in Citrine occurred also due to the fact 334 our approach did not only target sox10 E2, E5 and E7 enhancers within the endogenous sox10 335 locus, but also within the regulatory region included in the ox117 BAC allele driving 336 dCas9-SID4x. As a consequence, Citrine and dCas9-SID4x expression was progressively 337 decreased and with it lessened the effect of epigenome modulation. To quantify this 338 phenomenon, we decided to focus on initial stages dCas9-SID4x activity to avoid the decrease in 339 its activity (and thus release of inhibition) due to the described regulatory conundrum. Three 340 different embryos (+/-Ac/Ds sgRNAs) were subjected to the same immunohistochemistry 341 protocol and imaged; dCas9-SID4x + cells were counted on individual slices [i.e. scenario
342
(1)+(2)] and scenario (2), see Materials & Methods, Supp.Material). The knockdown effect was 343 calculated as a ratio of Sox10 + /dCas-SID4x + ** cells in dCas9-SID4x + (* + **) counted cells 344 (Fig.4B') . Similar to the sox9a lncRNA knockdown experiment, we showed that deactivating 345 these three enhancers modestly diminished Sox10 expression (p=0.02) ( Fig.4B') .
346
In conclusion, these results demonstrated the utility of our Ac/Ds approach as an exploratory 347 tool to cell-specifically probe enhancers in order to elucidate their function in vivo, without the 348 need for or prior to laborious generation of stable transgenic lines for further characterisation. A CRISPRi was performed on three sox10 enhancers described earlier (E2, E5 and E7) by simultaneously microinjecting five AcDs-U6a:sgRNAs per enhancer (15 in total) into ox117 incrossed embryos. Immunohistochemistry followed by confocal imaging to detect Citrine and Sox10 proteins was used as a qualitative and quantitative readout of interference. mRNA was purified under RNase-free conditions using phenol-chloroform followed by ethanol 387 precipitation and the pellet resuspended in RNase-free water. mRNA quality was assessed by 388 gel electrophoresis (sharp intact band without degradation) and quantified using Qubit TM RNA 389 HS Assay kit (Q32852, ThermoFisher). For long term storage in −80 • C the purified mRNA 390 was prepared as 1 µL aliquots and limited to one freeze-thaw cycle. Prior to use, an aliquot is 391 freshly diluted with nuclease-free water and the excess discarded after use. 392 6. Ac/Ds microinjections 393 All microinjections were performed by injecting 2.3 nL into the blastula of one-cell stage 394 embryos within 5 to 20 mins post fertilisation. To prepare microinjection aliquots, Miniprepped 395 plasmids in Elution Buffer were diluted at least 20-fold with nuclease-free water. The following 396 conditions have been optimised using the Nanoject II system (Drummond Scientific) and may 397 have to be adjusted if using a different microinjector. the same laser and acquisition settings throughout. Raw images were rendered on Imaris 409 (Bitplane) as "Spots" and "Surfaces" for Hoechst and GFP channels, respectively. To compute 410 total GFP intensity (x ), GFP Mean Intensity values of "Spots" with d >0 (d =distance from 411
Hoechst "Spot" to GFP "Surface"), was summed. GFP intensity per 1 µm 2 "Surface" Area, y, 412 was calculated by dividing x with total "Surface" Area detected. GFP intensity for 50 µm 2 , 413 y*50, was plotted as a bar chart. (Mali et al., 2013) were generated using BAC recombination followed by Tol2 transgenesis as 432 previously described (Suster et al., 2011 , Trinh et al., 2017 . Recombination cassettes were regions on the same strand were merged using bedtools merge (Quinlan and Hall, 2010)) to 505 'recapitulate' amplicon fragments prior to tagmentation during library prep. To identify regions 506 with significant signal over background in mapped reads (10 to 50-fold enrichment, ergo 507 integration sites), peaks were called using MACS2 callpeaks (Zhang et al., 2008) with -g 508 1.41e9 -m 10 50 --nomodel --shiftsize X -q 0.01 parameters, where X=library 509 fragment size/2. To filter out 'high-confidence' called peaks, bedtools intersect was used to 510 retrieve common peaks found in both forward and reverse samples overlapping by at least 1bp. 511
If desired, peaks that overlapped annotated repeat elements by at least 1bp were removed using 512 bedtools subtract. Genome ontology analysis of peaks were performed using HOMER Embryos were fixed in 4% paraformaldehyde (PFA) for 45 minutes at room temperature (RT). 517
After washing, embryos were blocked using 10% goat serum in PBT (PBS, 0.5% Triton, 2% 518 DMSO) for 1 hour at RT. Primary antibodies used were chicken anti-GFP (to detect eGFP or 519
Citrine) (ab13970, Abcam) and rabbit anti-zfSox10 (GTX128374, GeneTex) in a 1:200 dilution, 520 added overnight at 4 • C. Secondary antibodies used were donkey anti-rabbit 568nm (A10042, 521
ThermoFisher) and goat anti-chicken 647nm (A21449,ThermoFisher) in 1:400 dilution each, 522 together with Hoechst reagent (H3569, ThermoFisher) in a 1:1000 dilution to label nuclei -all 523 added for 2 hours at RT. After washing to remove excess, embryos were imaged using a LSM780 524 confocal microscope (Zeiss). 
